Providing researchers with a wide range of high quality, innovative genetic cancer diagnostic services at the Brigham.
Menu
Providing researchers with a wide range of high quality, innovative genetic cancer diagnostic services at the Brigham.
BWH’s Center for Advanced Molecular Diagnostics (CAMD) is a CLIA-certified clinical molecular and cytogenetics diagnostics laboratory offering a wide range of high quality, innovative genetic cancer diagnostic services.
Within CAMD, the Translational Biomarker Core (TBC, formerly the CAMD Research Core) provides the same clinical grade sample preparation and diagnostic testing services on a fee for service basis to support both local and global research communities. Studies performed in partnership with TBC span grant-funded academic research to active academic and industry sponsored clinical trials.
